PCR80 Patient Preferences for Stages II/III and Stage IV Melanoma Treatments in the UK
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2519
https://www.valueinhealthjournal.com/article/S1098-3015(23)05649-8/fulltext
Title :
PCR80 Patient Preferences for Stages II/III and Stage IV Melanoma Treatments in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05649-8&doi=10.1016/j.jval.2023.09.2519
First page :
Section Title :
Open access? :
No
Section Order :
11862